Green Cross Is Latest Korean Pharma To Struggle Under Regulatory Headwinds
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Green Cross Corp. has continued a trend among Korean pharma companies by posting relatively sluggish second quarter results